VANTAGE MHEALTHCARE INC Inactive Instrument
Vantage Mhealthcare Inc Stock Other OTC
Equities
US92210G1076
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Jan. 02 | Nano Mobile Healthcare, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Nano Mobile Healthcare, Inc. Announces Executive Changes | CI |
Financials (USD)
| Sales 2021 | - | Sales 2022 | - | Capitalization | 882K |
|---|---|---|---|---|---|
| Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 | - |
| Net cash position 2021 * | - | Net Debt 2022 | 0.51 | EV / Sales 2022 | - |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.18% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Roy Watson
CEO | Chief Executive Officer | - | 23-09-10 |
Robert Chicoski
BRD | Director/Board Member | 81 | 17-05-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Katzaroff
BRD | Director/Board Member | 66 | 17-05-30 |
Robert Chicoski
BRD | Director/Board Member | 81 | 17-05-29 |
Roy Watson
CEO | Chief Executive Officer | - | 23-09-10 |
Nano Mobile Healthcare, Inc. develops small, hand-held screening devices, which utilize nanotechnology to detect the presence of specific compounds in the breath. The Company's first products are the convergence of nano-electronics, bio-informatics, and wireless technology. The products are based on patented technology invented by the National Aeronautics and Space Administration (NASA), which is license to Nanobeak, and further sub-licensed to the Company. The Company is focused on its screening for the presence of disease or the use of drugs.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.07% | 189B | |
| -2.61% | 107B | |
| -3.74% | 67.81B | |
| +8.44% | 51.87B | |
| +14.04% | 46.67B | |
| -0.77% | 38.68B | |
| +7.58% | 27.73B | |
| +2.52% | 26.6B | |
| +4.43% | 26.34B |
